Deals

Cases

SOON

News

Moves

The Sponsor

Loading page...

Stay informed with the latest news and developments in the legal industry. Explore profiles of top law firms and their talented professionals. Empowering the legal community with real-time insights and comprehensive firm profiles.

Directories

Deals

News

Moves

Firms

Account

Profile

SOON

Sign in

SOON

Analysis

AI Rankings

Deal Activity

Salaries

SOON

Firm Comparison

SOON

© The Sponsor. All rights reserved.

Terms & Conditions | Privacy Policy

Joey Chau Profile, Deals & Rankings | The Sponsor - The Sponsor

Kirkland & Ellis LLP

Joey Chau

Joey Chau

Qualified in England & Wales (UK) & Hong Kong, 2008

Partner for 9 years

Practice Areas

Mergers & Acquisitions

Private Equity

Corporate

Professional Bio

Joey Chau is a Partner at Kirkland & Ellis in Hong Kong, where she co-heads the strategic M&A practice in Asia. With a strong focus on private equity and complex transactions, Joey is a trusted advisor to leading financial investors. Her expertise in high-profile take-private transactions has earned her recognition in the legal community, including being named in the 'Women Dealmakers Hall of Fame' by IFLR Asia-Pacific Awards. Joey is also a member of the Takeovers and Mergers Panel and the Takeovers Appeal Committee of the Securities and Futures Commission of Hong Kong. She holds an LLB from King's College London.

Kirkland & Ellis LLP

Hong Kong

+85237613300

Representative Matters

Joey Chau's representative experience includes advising:

Private Equity Transactions

Carlyle on its investment in MicroPort, HUTCHMED, and its acquisition of McDonald's operations in China and Hong Kong
Oaktree Capital on its cornerstone investments in S.F. Holding, China Resources Beverage, China Tourism Group Duty Free Corporation, Thai Life Insurance, Hengrui Pharmaceuticals, and JD Logistics
PAG on its take-private of Shandong Fengxiang
Ally Bridge Group on its take-private of Shandong Luoxin Pharmaceutical Group

Public M&A and Take-Private Transactions

MicroPort CardioFlow Medtech Corporation on its proposed merger with MicroPort Cardiac Rhythm Management (CRM)
CIMC Vehicles on its privatization
MoneyHero Group on its business combination with Bridgetown
Edding Group on its reverse takeover with Genor Biopharma

Financial Advisory for Takeovers and Mergers

J.P. Morgan, as financial advisor, on the take-private of L’Occitane International S.A. and Sichuan Languang Justbon Services Group
UBS, as financial adviser, on the merger of Guotai Junan and Haitong Securities
CICC, as financial adviser, on the take-private of Shanghai Henlius Biotech, Bank of Jinzhou, Inner Mongolia Yitai Coal, EVOC Intelligent Technology, and others

Investments and Acquisitions

Starwood Capital Group on the take-private of ESR
Ascendent Capital Partners on its takeover of China Automation Group
China Energy Investment Corp. Ltd. on its acquisition deal
Sequoia China on its investment in GDS Holdings

gradient

Deal Summary

0

Deals

$0.0

Total Value

Clients Worked With

21st Century FoxAdvantage PartnersAlly Bridge GroupArtisan Acquisition Corp.Ascendent Capital PartnersBain CapitalBank of America Merrill LynchBeijing WangfujingBlackstoneCar Inc.CarlyleCCB InternationalChina Energy Investment Corp. Ltd.China Grand Automotive ServicesCIMC VehiclesCITIC CapitalCITIC SecuritiesCMGE Technology GroupCOFCO BeveragesCOFCO Coca-Cola BeveragesEdding GroupGL CapitalGLPHuatai Financial HoldingsHypebeastIndependent Board Committee of Vinda International HoldingsJ.P. MorganJD PropertyLi & FungLilly Asia VenturesLink REITLoyal Valley CapitalMicroPort Scientific CorporationMideaMoneyHero GroupMorgan StanleyMRINan Fung GroupNCGA HoldingsNetDragonOaktree CapitalOcean Link PartnersPAGPCCWPokka CorporationPower Heritage GroupPower Heritage Group Ltd.SciClone PharmaceuticalsSequoia China Infrastructure FundShanghai Pudong Science and Technology InvestmentSkyworth GroupStarwood Capital GroupThe Carlyle GroupTPV TechnologyUBS AGVipshopWynn MacauZG GroupCICC

Related Deals

Kirkland & Ellis LLP

Kirkland & Ellis advises Carlyle-backed ADICON on acquisition of Crown Bioscience from JSR Life Sciences

- ADICON Holdings Limited acquired the target/assets from JSR Life Sciences in a acquisition on not available. - Deal value was 204000000 Sector: Healthcare; Location: Global. - On the acquirer side, not available advised, led by Joey Chau, Brian Ho, Ryan Choi, Gary Chan.

Nov 14 2025

204M

Private Equity

Related News

Kirkland Advises PCCW on the HK$280 Million PIPE Investment in the De-SPAC Merger of HK Acquisition Corporation and Synagistics Pte. Ltd.

Kirkland Advises PCCW on the HK$280 Million PIPE Investment in the De-SPAC Merger of HK Acquisition Corporation and Synagistics Pte. Ltd.

Kirkland & Ellis represented Celestial Link Limited, an investment vehicle ultimately controlled by PCCW Limited (HKSE: 0008), on its HK$280 million PIPE investment as a lead investor in the de-SPAC merger of HK Acquisition Corporation (a SPAC listed in Hong Kong under the stock code 7841) and Synagistics Pte. Ltd. The transaction was signed and announced on June 28, 2024. The negotiated value of Synagistics in this transaction is HK$3.5 billion, and the committed PIPE investment as of the signing date is approximately HK$601 million. Synagistics is a leading data-driven digital commerce solutions platform in Southeast Asia with Alibaba as the controlling shareholder. The promoters of the SPAC entity include Dr. Chan Tak Lam Norman (the former Chief Executive of the Hong Kong Monetary Authority) and Ms. Tsang King Suen Katherine (the former Chairperson of Greater China of Standard Chartered Bank). This was the third de-SPAC transaction announced in Hong Kong. Read the announcement The team was led by corporate partner Joey Chau. The team also included corporate partner Brian Ho and registered foreign lawyers Leo Zhou and Sherry Fu.

Jul 10

Experience

Kirkland & Ellis

Kirkland & Ellis

Partner
2017 – Unknown
Associate
2017 – 2017
Partner
2016 – 2017
Partner | Corporate | M&A
2014 – 2016
Associate | Corporate | M&A
2011 – 2014

S

Kirkland & Ellis LLP

Kirkland & Ellis advises Centurium Capital, Temasek and True Light consortium on proposed take-private of ANE (Cayman) Inc.

- Centurium Capital, Temasek and True Light acquired the target/assets from ANE (Cayman) Inc. in a take-private on not available. - Deal value was 1840000000 Sector: Logistics; Location: Global. - On the acquirer side, counsel was not available, led by Joey Chau, Brian Ho, Leo Zhou, Jiayi Wang, Sherry Fu, Jacqueline Zheng, Karen Ho, Sean Zhang, Aleks Bakic, Jennifer Feng, Jerry Choi, Nicole Yang, Alasdair Balfour, Mark Gardner, Michael Thorpe.

Oct 29 2025

2B

Private Equity

Kirkland & Ellis LLP

Kirkland & Ellis advises PAG on proposed privatization of Shandong Fengxiang

- PAG acquired the target/assets from Shandong Fengxiang Co., Ltd. in a privatization on not available. - Deal value was 2300000000 Sector: Food; Location: Global. - On the acquirer side, not available advised, led by Joey Chau, Brian Ho.

Apr 14 2025

2B

Private Equity

Kirkland & Ellis LLP

Kirkland & Ellis advises Skyworth Group Limited on HK$139 million share buy-back offer

- Skyworth Group Limited executed a share buy-back from not available in a Share Buy-Back on not available. - Deal value was 139487179 Sector: Consumer Electronics; Location: not available. - On the acquirer side, not available advised, led by Joey Chau, Brian Ho.

Mar 31 2025

139M

M&A

Kirkland & Ellis LLP

Kirkland & Ellis advises UBS as financial adviser to Guotai Junan Securities and Clifford Chance advises Haitong Securities on the merger of Guotai Junan Securities and Haitong Securities via share exchange.

- Guotai Junan Securities Co., Ltd. merged with Haitong Securities Co., Ltd. in a merger on not available. - Deal value was 2300000000 Sector: Financial Services; Location: not available. - On the acquirer side, not available advised, led by Joey Chau, Brian Ho.

Mar 18 2025

2B

M&A

Kirkland & Ellis LLP

Kirkland & Ellis advises Victory III Co., Ltd on proposed privatization of Vesync

- Victory III Co., Ltd acted as the acquirer in this Privatization transaction. - The acquisition targeted assets operating in the Consumer Products sector. - The transaction was announced on 30 Dec 2024 with a reported value of 12000000000.0.

Dec 30 2024

12B

M&A

...

1 min

Kirkland Advises on the Proposed Privatization of Vesync

Kirkland Advises on the Proposed Privatization of Vesync

Kirkland & Ellis is advising Victory III Co., Ltd as the offeror on its proposed privatization of Vesync Co., Ltd (HKSE: 2148) by way of a scheme of arrangement. The offeror is indirectly wholly-owned by the founders of Vesync. Vesync is principally engaged in designing, developing and selling small home appliances. The transaction was announced on December 27, 2024. Read the transaction press release The Kirkland team includes corporate lawyers Joey Chau, Leo Zhou and Brian Ho; and debt finance lawyers Jacqueline Zheng and Karen Ho.

Dec 30

1 min

Kirkland Represents Skyworth Group on its Privatisation through Share Buy-Back Scheme and Listing of its Photovoltaic Business through Distribution in Specie

Kirkland Represents Skyworth Group on its Privatisation through Share Buy-Back Scheme and Listing of its Photovoltaic Business through Distribution in Specie

Kirkland & Ellis is advising Skyworth Group Limited (HKSE: 751) on its delisting from the Hong Kong Stock Exchange by way of a share buy-back scheme of arrangement and the concurrent listing of its photovoltaic business in Hong Kong by way of distribution in specie. The transaction was announced on January 20, 2026, and is subject to customary conditions. Read the transaction announcement The Kirkland team includes corporate lawyers Joey Chau and Brian Ho.

Jan 22

1 min

Kirkland Advises CITIC Capital on Sale in AsiaInfo Technologies

Kirkland Advises CITIC Capital on Sale in AsiaInfo Technologies

Kirkland & Ellis advised CITIC Capital on its HK$1.46 billion sale of a 20.32% stake in AsiaInfo Technologies Limited (HKSE: 1675) to AsiaInfo Security Technologies Co., Limited (688225.SH). The transaction was signed on January 16, 2024 and closed on November 8, 2024. The Kirkland team included corporate lawyers Joey Chau, Nelson Ni, Sherry Fu and Chuqing Ren.

Nov 12

1 min

Kirkland Represents Morgan Stanley in the MGOs Made By An Ke Technology and Ping An Overseas Holdings in respect of the Securities of Lufax Holding

Kirkland Represents Morgan Stanley in the MGOs Made By An Ke Technology and Ping An Overseas Holdings in respect of the Securities of Lufax Holding

Kirkland & Ellis is advising Morgan Stanley Asia Limited, as the financial adviser to the joint offerors, An Ke Technology Company Limited and China Ping An Insurance Overseas (Holdings) Limited, each being a wholly-owned subsidiary of Ping An Insurance (Group) Company of China, Ltd. (HKSE: 2318; SSE: 601318), in the possible mandatory unconditional cash offers for all the shares, ADSs, outstanding options and performance share units of Lufax Holding Ltd (HKSE: 6623; NYSE: LU). The MGOs were triggered by the election for the scrip dividends by the joint offerors under the scrip dividend scheme of Lufax Holding. Read the announcement The Kirkland team is led by Hong Kong corporate partners Joey Chau, Brian Ho and Nelson Ni and U.S. corporate partners Michael Kim and Min Lu.

Jul 5

1 min

Kirkland Represents Edding Group on its Proposed Merger and Reverse Takeover with Genor Biopharma

Kirkland Represents Edding Group on its Proposed Merger and Reverse Takeover with Genor Biopharma

Kirkland & Ellis is representing Edding Group Company Limited, an integrated biopharmaceutical company focusing on research, development and commercialization of promising therapeutics in areas with considerable demand in the PRC, in connection with a proposed merger and reverse takeover with Genor Biopharma Holdings Limited, a Hong Kong-listed biopharmaceutical company under Chapter 18A that focuses on developing and commercializing oncology and immunology drugs. The deal represents the first ever reverse takeover relating to a Chapter 18A listed company and the only announced reverse takeover case in Hong Kong recently. The proposed merger is expected to bring complementary and synergetic effects to both Genor Biopharma and Edding Group, laying an important foundation for the sustainable development of the enlarged group post-merger closing. The transaction is subject to customary closing conditions. Read the announcement The Kirkland team included capital markets lawyer Mengyu Lu; corporate lawyers Joey Chau, Ashlee Wu, Leo Zhou, Chuanwen Wang and Rock Liu; and corporate registered foreign lawyer Sherry Fu.

Oct 7

1 min

...

Skadden

Associate | Corporate
2011 – 2011

M

Mallesons Stephen Jaques

Solicitor
2008 – 2011
Trainee Solicitor
2006 – 2008

Education

LLB, King's College London
2005